Veralto Corporation $VLTO Stake Lowered by Candriam S.C.A.

Key Points

• Candriam S.C.A. has sold 2,881 shares of Veralto Corporation, reducing its ownership to approximately 258,687 shares, valued at $25,209,000.
• Analysts have issued mixed ratings for Veralto, with a consensus rating of "Moderate Buy" and an average price target of $113.43.
• Veralto reported earnings of $0.93 per share for the last quarter, which exceeded expectations and marked a 6.4% increase in revenue year-over-year.

Candriam S.C.A. decreased its holdings in Veralto Corporation (NYSE:VLTO - Free Report) by 1.1% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 258,687 shares of the company's stock after selling 2,881 shares during the period. Candriam S.C.A. owned approximately 0.10% of Veralto worth $25,209,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Bernard Wealth Management Corp. purchased a new position in shares of Veralto in the 4th quarter valued at $30,000. Opal Wealth Advisors LLC acquired a new stake in Veralto in the 1st quarter valued at $45,000. Grove Bank & Trust raised its position in Veralto by 198.2% in the first quarter. Grove Bank & Trust now owns 510 shares of the company's stock valued at $50,000 after purchasing an additional 339 shares during the period. Global Financial Private Client LLC lifted its stake in shares of Veralto by 95.1% during the first quarter. Global Financial Private Client LLC now owns 593 shares of the company's stock worth $58,000 after purchasing an additional 289 shares in the last quarter. Finally, Putney Financial Group LLC purchased a new stake in shares of Veralto in the fourth quarter worth about $60,000. 91.28% of the stock is currently owned by hedge funds and other institutional investors.

Veralto Stock Down 0.3%

Shares of VLTO stock traded down $0.27 during trading hours on Tuesday, hitting $106.88. 177,230 shares of the company were exchanged, compared to its average volume of 1,358,534. The stock has a market capitalization of $26.52 billion, a price-to-earnings ratio of 29.85, a P/E/G ratio of 3.60 and a beta of 0.91. Veralto Corporation has a one year low of $83.86 and a one year high of $115.00. The business's 50-day simple moving average is $103.74 and its two-hundred day simple moving average is $99.22. The company has a debt-to-equity ratio of 1.00, a quick ratio of 2.06 and a current ratio of 2.32.

Veralto (NYSE:VLTO - Get Free Report) last announced its quarterly earnings data on Monday, July 28th. The company reported $0.93 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.04. Veralto had a return on equity of 41.45% and a net margin of 16.65%.The firm had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.34 billion. During the same period in the previous year, the company earned $0.85 earnings per share. Veralto's quarterly revenue was up 6.4% on a year-over-year basis. Veralto has set its FY 2025 guidance at 3.720-3.800 EPS. Q3 2025 guidance at 0.910-0.950 EPS. Sell-side analysts predict that Veralto Corporation will post 3.66 EPS for the current fiscal year.

Insider Buying and Selling at Veralto

In other news, SVP Surekha Trivedi sold 848 shares of the firm's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $100.55, for a total value of $85,266.40. Following the transaction, the senior vice president directly owned 8,433 shares in the company, valued at approximately $847,938.15. This trade represents a 9.14% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.36% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently commented on VLTO shares. Royal Bank Of Canada raised their target price on Veralto from $104.00 to $108.00 and gave the company a "sector perform" rating in a report on Wednesday, July 30th. Northcoast Research started coverage on shares of Veralto in a research note on Tuesday, May 6th. They set a "buy" rating and a $110.00 price objective on the stock. Wolfe Research upgraded shares of Veralto from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, July 30th. Raymond James Financial assumed coverage on shares of Veralto in a research note on Tuesday. They set a "market perform" rating on the stock. Finally, Stifel Nicolaus set a $120.00 price objective on shares of Veralto and gave the stock a "buy" rating in a report on Wednesday, July 30th. Five investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $113.43.

About Veralto

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.